http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103327981-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 2011-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d850d00396717d475d6a91a6c2be55a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb6de564e0b42ed785cf3e9076731fd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c9f26fe1e9d450c2a4dffab96242250
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5776543c06a0dd6ec789738216e547fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c7a16f619968af7c285c6eadc4e01e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fb264e6c36044a9fba2f67134bcd8b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743cd126250c57fb45ba089f0dc09ec6
publicationDate 2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103327981-A
titleOfInvention Method for treating retinal disease
abstract Disclosed herein is a method of treating a retinal disorder comprising administering to a patient in need of such treatment a drug selected from the group consisting of olanzapine, certain metabolites thereof, clozapine, and n-desmethylclozapine. Set of compounds.
priorityDate 2010-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004103263-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070249-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101437478-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5744468-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421150522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414879139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426598988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12535778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465008217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163457056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67338

Total number of triples: 34.